NATCO Pharma share price opened sharply lower on Thursday after the company reported a 37.75% YoY decline in net profit to Rs 132.4 crore for Q3FY25. Formulation exports fell significantly, while API revenue showed growth. Despite the drop in profits, the company declared a third interim dividend of Rs 1.50 per share. The stock has a target price of Rs 1,349.
